Effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism

被引:42
|
作者
Yang, Mingzheng [1 ]
Kan, Lin [2 ]
Wu, Lianye [1 ]
Zhu, Yingchun [1 ]
Wang, Qing [1 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Qingpu Branch, Dept Nephrol, 1158 Gongyuan East Rd, Shanghai 201700, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Qingpu Branch, Dept Clin Lab, Shanghai 201700, Peoples R China
关键词
baicalin; diabetic nephropathy; renal function; therapeutic mechanism; OXIDATIVE STRESS; DISEASE; CELLS; APOPTOSIS; INJURY; STAGE; VEGF;
D O I
10.3892/etm.2019.7181
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study observed the effect of baicalin on blood glucose and renal function in patients with diabetic nephropathy and explored its mechanism of action. A total of 95 patients diagnosed with diabetic nephropathy by clinical and laboratory examinations were selected and randomly divided into a control and treatment group. The control group included 45 patients who were treated with routine symptomatic treatment. The remaining 50 patients in the treatment group received baicalin, in addition to routine symptomatic treatment. The treatment course was 6 months. Following this, the changes of indicators such as fasting plasma glucose (FPG), glycosylated hemoglobin (HBA1c), aldose reductase (AR) activity, 24-h urinary microalbumin, urinary 2-microglobulin (2-MG) and urinary albumin excretion rate (UAER) were compared before and after treatment; at the same time, the variations of indexes, including superoxide dismutase (SOD), glutathione peroxidase (GSH-px), nuclear factor -light-chain-enhancer of activated B cells (NF-B), transforming growth factor-1 (TGF-1) and vascular endothelial growth factor (VEGF) were detected. Compared with those in the control group, baicalin had little effect on the treatment group's FPG and HBA1c, but it clearly reduced the AR activity and the difference was significant (P<0.05). Baicalin visibly decreased the 24-h urinary microalbumin, urinary 2-MG and UAER (P<0.05) and had notable effect on improving renal function. Following treatment, compared with those in the control group, baicalin distinctly increased the levels of SOD and GSH-px (P<0.05) and decreased the content of NF-B and VEGF (P<0.05), however, its impact on the expression of TGF-1 was not statistically significant (P>0.05). The results showed that baicalin may improve the renal function in patients with diabetic nephropathy and delay the progression of diabetic nephropathy through various ways, including anti-inflammation and anti-oxidation.
引用
收藏
页码:2071 / 2076
页数:6
相关论文
共 50 条
  • [1] Effects of Metformin on Renal Function, Cardiac Function, and Inflammatory Response in Diabetic Nephropathy and Its Protective Mechanism
    Zhang, Zhiping
    Dong, Hongyu
    Chen, Jiaqi
    Yin, Min
    Liu, Feng
    DISEASE MARKERS, 2022, 2022
  • [2] Effect of Spironolactone on Endothelial and Renal Function in Type 2 Diabetic Patients with Nephropathy
    Bountouvis, Nikolaos
    Skoura, Evangelia
    Moutzouris, Dimitrios-Anestis
    Pastromas, Sokratis
    Siamatras, Thomas
    Politis, Emmanouil
    Rontogianni, Phivi
    Koulouris, Spyridon
    Apostolou, Theofanis
    Ioannidis, Georgios
    DIABETES, 2009, 58 : A212 - A213
  • [3] Renal function in diabetic nephropathy
    Dabla, Pradeep Kumar
    WORLD JOURNAL OF DIABETES, 2010, 1 (02) : 48 - 56
  • [4] RENAL FUNCTION IN DIABETIC NEPHROPATHY
    ROBERTSON, JA
    GRAY, CH
    BAYNES, AH
    ARCHIVES OF INTERNAL MEDICINE, 1951, 87 (04) : 570 - 582
  • [5] THE EFFECT AND MECHANISM OF DAPAGLIFLOZIN ON RENAL FIBROSIS IN RATS WITH DIABETIC NEPHROPATHY
    Chen, Xinnan
    Li, Zengyan
    Chen, Fangxu
    Wang, Caili
    ACTA MEDICA MEDITERRANEA, 2022, 38 (04): : 2451 - 2458
  • [6] THE EFFECT AND MECHANISM OF DAGLIEJING ON RENAL FIBROSIS IN RATS WITH DIABETIC NEPHROPATHY
    Tan, Feng
    Wang, Jiaying
    Ge, Binxiao
    Wu, Chenji
    Feng, Yuan
    ACTA MEDICA MEDITERRANEA, 2022, 38 (06): : 3683 - 3690
  • [8] Protective effect of an oral adsorbent on renal function in chronic renal failure: Determinants of its efficacy in diabetic nephropathy
    Sanaka, T
    Akizawa, T
    Koide, K
    Koshikawa, S
    THERAPEUTIC APHERESIS AND DIALYSIS, 2004, 8 (03): : 232 - 240
  • [9] Renal structure and function in type 2 diabetic patients with or without diabetic nephropathy
    Christensen, PK
    DANISH MEDICAL BULLETIN, 2004, 51 (01) : 82 - 103
  • [10] Utility of urinary progranulin in patients with type 2 diabetic nephropathy and its correlation with renal function
    Rai, Abhishek
    Senthilkumar, Gandhipuram Periyasamy
    Mehalingam, Vadivelan
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (04) : 751 - 756